QSI News and Press, Quantum-Si Incorporated From 07/18/22

Jul. 18, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next generation single molecule protein sequencing, today announced that it will report financial...

ARK Invest’s 13F portfolio value decreased from $23.96B to $16.91B this quarter. Coinbase Global, Roku, Shopify, and Ginkgo Bioworks were increased while decreasing Spotify, Ionis Pharma, Vertex Pharma, and Sea Limited. The top three positions are Tesla, Zoom Video, and Rok...

Si Incorporated (NASDAQ:QSI) to join the broad-market Russell 2000 Index, effective after the U.S. market opens on June 27, 2022 according to a preliminary list of additions posted by FTSE Russell on June 3, 2022. “We are pleased Quantum-Si is set to join the Russell 2000® index, ...

First of its kind life sciences company continues focus on commercial launch of next-generation protein sequencing platform June 22, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life scie...

June 16, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Vikram Bajaj, Ph.D., co-founder and ...

Glenview Capital Management’s 13F portfolio value increased from $4.69B to $4.94B this quarter. The number of positions increased from 57 to 60. They increased Cigna, DXC Technology, Fiserv, US Foods Holding, Amazon.com, and Aptiv plc while decreasing McKesson, Bausch Health, F...

At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging (NNOX), ADMA Biologics (ADMA),&...

Quantum-Si demonstrates a path to enable >70% coverage of the human proteome and the identification of up to 90% of proteins, including post-translational modifications Company continues to advance the core technology as it progresses towards commercialization of its Platin...

May 25, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the 2022 Jefferies Heal...

May 17, 2022-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Pro...